Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles

Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis

Joanna Rejman, Volker Oberle, Inge S. Zuhorn et al. · Biochemical Journal · 2004 · 2.8K citations · Full text

Life Sciences, Biophysics, Cell Biology +17

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

W. Hiddemann · Blood · 2005 · 1.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +7

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

John W. Park, Keelung Hong, Dmitri B. Kirpotin et al. · PubMed · 2002 · 648 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies

Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press · Blood · 1998 · 571 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Sterically Stabilized Anti-HER2 Immunoliposomes:  Design and Targeting to Human Breast Cancer Cells <i>in Vitro</i>

Dmitri B. Kirpotin, John W. Park, Keelung Hong et al. · Biochemistry · 1997 · 441 citations

Pharmacy, Oncology, Pharmacology +17